WO2023143988 - NEW COMPOUNDS AND THEIR USE AS ANTI-AGING AGENT OR AS EXERCISE ENHANCER
National phase entry is expected:
Publication Number
WO/2023/143988
Publication Date
03.08.2023
International Application No.
PCT/EP2023/051163
International Filing Date
19.01.2023
Title **
[English]
NEW COMPOUNDS AND THEIR USE AS ANTI-AGING AGENT OR AS EXERCISE ENHANCER
[French]
NOUVEAUX COMPOSÉS ET LEUR UTILISATION COMME AGENT ANTI-ÂGE OU COMME ACTIVATEUR D'EXERCICE
Applicants **
ETH ZURICH
Inventors
CARREIRA, Erick
RISTOW, Michael
THOMAS, Carolin
ERNI, Reto
Priority Data
22153519.8
26.01.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
* |
| Recordal of a Change of the Applicant's Name/Address | * |
| Type of Assignment | * |
| Applicant's Legal Status | * |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under | * |
| Patent Delivery | * |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2557 | |
| EPO | Filing, Examination, Granting | 10566 | |
| Japan | Filing, Examination, Granting | 2183 | |
| South Korea | Filing, Examination, Granting | 2106 | |
| USA | Filing, Examination, Granting | 6390 |
Total:
23,802
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
alkynyl residue.[French]
linéaire ou ramifié.